PTC Therapeutics, Inc. (PTCT)

SEC filing

PTC Therapeutics, Inc.

PTCT · CIK 1070081

4 · Aug 19, 2026 · EXEC. VP AND CLO Boulding Mark Elliott sold 2,813 shares at $72.57/share ($204.1K); exercised options for 5,626 shares

EXEC. VP AND CLO Boulding Mark Elliott sold 2,813 shares at $72.57/share ($204.1K); exercised options for 5,626 shares

xslF345X06/form4-08192026_050801.xml

xslF345X06/form4-08192026_050801.xmlSEC.gov

Graphics and non-inline formats (not embedded below).